LONDON (Reuters) – Almost 200 people have received GlaxoSmithKline’s experimental Ebola vaccine in trials in the United States, Britain, Mali and Switzerland, and the safety data so far are “very satisfactory”, scientists said on Monday.
The trials, which began just over two months ago, have been using healthy volunteers, rather than patients with Ebola, to test whether the vaccine is safe for humans.
LONDON (Reuters) – More and more infections in Europe are proving able to evade even the most powerful, last-resort antibiotics, posing an alarming threat to patient safety in the region, health officials said on Monday.
Releasing annual data on antibiotic resistant superbugs, the European Center for Disease Prevention and Control (ECDC) said bacterial infections resistant to carbapenems — a major last-line class of antibiotics used to treat hospital-acquired superbugs — are ever more common in the European Union.
LONDON (Reuters) – Progress toward wiping out measles worldwide has stalled, with deaths from the highly contagious disease rising last year and poor vaccine coverage leading to large outbreaks, the World Health Organization (WHO) said on Thursday.
More than 145,000 people died of measles in 2013, up from 122,000 in 2012, the WHO said. Epidemics in China, Congo and Nigeria contributed to this, but there were also outbreaks in the WHO’s European region, including in Georgia, Turkey and Ukraine.
LONDON (Reuters) – The rate of women dying in childbirth in West African countries hit by the Ebola epidemic is soaring, with as many as one in seven at risk of death as fear of contact with bodily fluids prevents people helping them, aid charities warned on Tuesday.
The United Nations Population Fund estimates that 800,000 women in Sierra Leone, Guinea and Liberia are due to give birth in the next 12 months.
LONDON, Nov 11 (Reuters) – British scientists say they have
found the best way yet to analyse the effects of smoking on the
brain — by taking functional magnetic resonance imaging (fMRI)
scans of people while they puff on e-cigarettes.
In a small pilot study, the researchers used electronic
cigarettes, or e-cigarettes, to mimic the behavioural aspects of
smoking tobacco cigarettes, and say future studies could help
scientists understand why smoking is so addictive.
LONDON (Reuters) – Scientists who unlocked the genetic code of bacteria grown from a soldier who died of dysentery in World War I say it revealed a superbug already resistant to penicillin and other antibiotics decades before they were in common use.
The discovery sheds light on the history of antibiotic resistance – now a global health threat – and offers fresh clues on how to tackle dysentery, a disease that kills hundreds of thousands of children every year in developing countries.
LONDON (Reuters) – A new hepatitis C vaccine from GlaxoSmithKline based on the same technology as an experimental Ebola shot being fast-tracked through human trials has shown promise in early clinical tests, prompting strong and broad immune responses.
Researchers testing the vaccine — the first hepatitis C vaccine to reach second stage clinical trials — said their results in a group of 15 healthy human volunteers showed it was very safe and well tolerated, and generated immune responses of a strength never seen before in a vaccine against this disease.
LONDON, (Reuters) – Giving the millions of women who need it contraception and pregnancy advice will help avoid illness, disadvantage and poverty for current and future generations, Melinda Gates said on Monday.
The co-founder of the Bill & Melinda Gates Foundation told Reuters she is encouraged by progress in the past two years in putting family planning at the centre of woman and child health programmes, but says more needs to be done to ensure all women can choose freely whether and when to have children.
LONDON, Nov 3 (Reuters) – Giving the millions of women who need it contraception and pregnancy advice will help avoid illness, disadvantage and poverty for current and future generations, Melinda Gates said on Monday.
The co-founder of the Bill & Melinda Gates Foundation told Reuters she is encouraged by progress in the past two years in putting family planning at the center of woman and child health programs, but says more needs to be done to ensure all women can choose freely whether and when to have children.
GENEVA/LONDON (Reuters) – Trials of Ebola vaccines could begin in West Africa in December, a month earlier than expected, and hundreds of thousands of doses should be available for use by the middle of next year, the World Health Organization said on Friday.
Vaccines are being developed and made ready in record time by drugmakers working with regulators, the U.N. health agency said, but questions remain about their safety and efficacy which can only be settled by full clinical trials.